NCT04539678View on ClinicalTrials.gov

SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications

CompletedOBSERVATIONAL
Enrollment

253

Participants

Timeline

Start Date

May 21, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Thrombotic PatientsDiagnosis of Myeloproliferative NeoplasiaImpact of Treatment With Cytoreducing Agent
Trial Locations (1)

44093

Nantes University Hospital, Nantes

All Listed Sponsors
collaborator

French Intergroup of Myeloproliferative syndromes

UNKNOWN

lead

Nantes University Hospital

OTHER

NCT04539678 - SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications | Biotech Hunter | Biotech Hunter